Congress targets syphilis crisis in pregnant women with Medicaid guidance
H.R. 3866 — Maternal and Infant Syphilis Prevention Act · Filed by Juan Ciscomani (R-AZ) · 4 cosponsors · Introduced Jun 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the Secretary of Health and Human Services to issue guidance within 12 months on best practices for screening and treating congenital syphilis (syphilis transmitted from mother to infant) under Medicaid and the Children's Health Insurance Program (CHIP). The guidance covers expanded screening for pregnant women and newborns, provider and patient education, telehealth integration, third-trimester and delivery-time testing, and treatment improvements. HHS must report back to Congress within 2 years on implementation.
Why we flagged it
The bill's operative mechanism is a directive to HHS to issue non-binding guidance on best practices for congenital syphilis prevention under existing Medicaid and CHIP programs. It is a public health measure, not a regulatory change, appropriation, or private benefit.
What the text implies
- Guidance may increase Medicaid/CHIP spending on syphilis screening and treatment if states adopt recommendations, though the bill does not mandate adoption or appropriate funds.
- Telehealth integration guidance could expand access in rural and underserved areas but depends on state implementation and existing telehealth infrastructure.
- The bill does not establish new screening requirements or mandate third-trimester testing; it only directs HHS to offer guidance, leaving adoption to state discretion.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill addresses a documented public health crisis—congenital syphilis cases have increased more than tenfold since 2012, causing stillbirths and infant deaths—by directing HHS to issue evidence-based guidance that states can use to improve screening and treatment. The mechanism is non-coercive (guidance and technical assistance), targets a vulnerable population (pregnant women and infants), and aims to prevent serious harm through earlier detection and treatment.
Who stands to gain
- pharmaceutical manufacturers (antibiotics for syphilis treatment)
- diagnostic testing companies (syphilis screening tests)
- telehealth service providers (if states adopt telehealth recommendations)
Named in the bill
Department of Health and Human Services (HHS), Medicaid, Children's Health Insurance Program (CHIP), Indian Health Service, Indian Tribes, Urban Indian organizations, House Committee on Energy and Commerce, Senate Committee on Health, Education, Labor and Pensions, Senate Committee on Finance
Where it stands
4 cosponsors: 3 Democrats, 1 Republicans.
- Jun 10, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jun 10, 2025 — Referred to House Committee on Natural Resources and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (4,766 characters) on Aug 19, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress targets syphilis crisis in pregnant women with Medicaid guidance” QuorumCivic. https://share.quorumcivic.app/bill/119/hr3866 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.